Express Scripts (ESRX) Rating Reiterated by SunTrust Banks
Express Scripts (NASDAQ:ESRX)‘s stock had its “buy” rating reiterated by analysts at SunTrust Banks in a research note issued on Friday. They currently have a $95.00 price target on the stock. SunTrust Banks’ price target indicates a potential upside of 17.47% from the company’s previous close.
Other equities analysts have also issued reports about the stock. Mizuho set a $67.00 target price on shares of Express Scripts and gave the company a “hold” rating in a report on Tuesday, October 24th. Raymond James Financial reaffirmed a “sell” rating on shares of Express Scripts in a report on Friday, December 15th. Robert W. Baird reaffirmed a “buy” rating and set a $92.00 target price (up from $81.00) on shares of Express Scripts in a report on Tuesday. Needham & Company LLC reaffirmed a “hold” rating on shares of Express Scripts in a report on Thursday, December 21st. Finally, Evercore ISI assumed coverage on shares of Express Scripts in a report on Thursday, January 4th. They set an “in-line” rating and a $78.00 target price for the company. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $77.09.
Express Scripts (ESRX) traded up $0.78 on Friday, reaching $80.87. 3,156,100 shares of the company’s stock were exchanged, compared to its average volume of 4,370,000. Express Scripts has a 12 month low of $55.80 and a 12 month high of $81.75. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. The stock has a market cap of $45,360.00, a price-to-earnings ratio of 13.43, a PEG ratio of 0.89 and a beta of 0.87.
Express Scripts announced that its Board of Directors has initiated a stock repurchase program on Monday, December 18th that allows the company to buyback 45,000,000 outstanding shares. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s leadership believes its stock is undervalued.
In other Express Scripts news, VP Phyllis S. Anderson sold 643 shares of Express Scripts stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $62.37, for a total transaction of $40,103.91. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Timothy C. Wentworth bought 8,000 shares of the stock in a transaction on Tuesday, October 31st. The shares were acquired at an average cost of $61.13 per share, for a total transaction of $489,040.00. Following the purchase, the chief executive officer now owns 98,628 shares in the company, valued at $6,029,129.64. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 17,644 shares of company stock worth $1,289,609. 0.68% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently made changes to their positions in the business. Burt Wealth Advisors boosted its position in shares of Express Scripts by 11.4% during the 2nd quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock valued at $108,000 after acquiring an additional 174 shares during the last quarter. Bank of Nova Scotia Trust Co. acquired a new position in shares of Express Scripts during the 3rd quarter valued at about $120,000. Monroe Bank & Trust MI boosted its position in shares of Express Scripts by 74.8% during the 3rd quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after acquiring an additional 970 shares during the last quarter. Capstone Investment Advisors Netherlands B.V. boosted its position in shares of Express Scripts by 49.3% during the 2nd quarter. Capstone Investment Advisors Netherlands B.V. now owns 2,797 shares of the company’s stock valued at $179,000 after acquiring an additional 924 shares during the last quarter. Finally, Nelson Roberts Investment Advisors LLC acquired a new position in shares of Express Scripts during the 3rd quarter valued at about $193,000. 88.28% of the stock is currently owned by institutional investors.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.